1 Min Read
March 13 (Reuters) - Aerpio Pharmaceuticals Inc:
* AERPIO REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* Q4 LOSS PER SHARE $0.23 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.